1. Fluckiger E., del Pozo E., von Werder K. Prolactin. Physiology, pharmacology and clinical findings. Springer-Verlag, Heidelberg, 1982, p. 153.
2. Chiodini P.G., Liuzzi A., Silvestrini F., Verde G., Cozzi R., Marsili M.T., Horowski R., Passerini F., Luccarelli G., Borghi P.G. Size reduction of a prolactin secreting adenoma during a long-term treatment with a dopamine agonist, lisuride. In: Proceedings of the International Symposium on Pituitary Microadenomas, 12214 October, 1978, Milan, Italy. Serono Symposia International, 1978, p. 64.
3. McGregor A.M., Scanion M.F., Hall K., Cook D.B., Hall R. Reduction in size of a pituitary tumor by bromocriptine therapy. N. Engl. J. Med. 300: 291, 1979.
4. Berezin M., Olchovsky D., Pines A., Tadmor R., Lunefeld B. Reduction of follicle-stimulating hormone (FSH) secretion in FSH- producing pituitary adenoma by bromocriptine. J. Clin. Endocrinol. Metab. 59: 1220, 1984.
5. Vance M., Evans W.S., Thorner M.O. Bromocriptine. Ann. Intern. Med. 100: 78, 1984.